SHR-2004

N/A

Report date: 2025/02/14 20:00:40

Base Information

Drug NameSHR-2004
Drug Alias NameSHR-2004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionFactor XIa inhibitorsCoagulation factor XI inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsArterial ThromboembolismDyslipidemiasVenous Thrombosis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Suncadia Medicine Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Suncadia Medicine Co LtdSuzhou Suncadia Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsArterial ThromboembolismDyslipidemiasVenous Thrombosis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A